Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Yau

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Canadian Journal of Kidney Health and Disease|March 31, 2025
Clinical Outcomes and Healthcare Utilization in Patients Receiving Maintenance Dialysis After the Onset of the COVID-19 Pandemic in Ontario, CanadaKyla L Naylor, Nivethika Jeyakumar, Yuguang Kang, et al.
Nature Communications|September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney diseaseKevin Yau, Alexandra Kurtesi, Freda Qi, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysisKevin Yau, Christopher T Chan, Kento T Abe, et al.
JAMA Network Open|September 2, 2021
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing HemodialysisKevin Yau, Kento T Abe, David Naimark, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
Diabetes Care|June 26, 2025
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Emergency Department Visits and Hospitalization in Patients With Chronic Kidney DiseaseKevin Yau, Joel G Ray, Nivethika Jeyakumar, et al.
Canadian Journal of Kidney Health and Disease|July 7, 2025
Clinical Outcomes and Health Care Utilization in Patients with Advanced Chronic Kidney Disease not on Dialysis After the Onset of the COVID-19 Pandemic in Ontario, CanadaCarol Wang, Yuguang Kang, Stephanie N Dixon, et al.
Clinical & Translational Immunology|March 31, 2022
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccinationKaren Colwill, Yannick Galipeau, Matthew Stuible, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Canadian Journal of Kidney Health and Disease|March 31, 2025
Clinical Outcomes and Healthcare Utilization in Patients Receiving Maintenance Dialysis After the Onset of the COVID-19 Pandemic in Ontario, CanadaKyla L Naylor, Nivethika Jeyakumar, Yuguang Kang, et al.
Nature Communications|September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney diseaseKevin Yau, Alexandra Kurtesi, Freda Qi, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysisKevin Yau, Christopher T Chan, Kento T Abe, et al.
JAMA Network Open|September 2, 2021
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing HemodialysisKevin Yau, Kento T Abe, David Naimark, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
Diabetes Care|June 26, 2025
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Emergency Department Visits and Hospitalization in Patients With Chronic Kidney DiseaseKevin Yau, Joel G Ray, Nivethika Jeyakumar, et al.
Canadian Journal of Kidney Health and Disease|July 7, 2025
Clinical Outcomes and Health Care Utilization in Patients with Advanced Chronic Kidney Disease not on Dialysis After the Onset of the COVID-19 Pandemic in Ontario, CanadaCarol Wang, Yuguang Kang, Stephanie N Dixon, et al.
Clinical & Translational Immunology|March 31, 2022
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccinationKaren Colwill, Yannick Galipeau, Matthew Stuible, et al.
Pageof 5